Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow
Monday, May 18, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

PFA has been a game-changer for heart patients—but there are still risks

Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

READ MORE >
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.
Share on Twitter Share on Facebook Share on Linkedin

PFA has been a game-changer for heart patients—but there are still risks

Share on Twitter Share on Facebook Share on Linkedin
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.
Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.
READ MORE >

Thousands of reprocessed EP catheters recalled

Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.

READ MORE >
Physician warning
Share on Twitter Share on Facebook Share on Linkedin

Thousands of reprocessed EP catheters recalled

Share on Twitter Share on Facebook Share on Linkedin
Physician warning
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
READ MORE >

Trump administration exempts doctors from work visa freeze

SCAI said reversing the processing hold allows physicians to continue serving patients and helps stabilize the workforce.

READ MORE >
President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.
Share on Twitter Share on Facebook Share on Linkedin

Trump administration exempts doctors from work visa freeze

Share on Twitter Share on Facebook Share on Linkedin
President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.
SCAI said reversing the processing hold allows physicians to continue serving patients and helps stabilize the workforce.
READ MORE >

Heartflow reports significant revenue growth as CCTA sees wider adoption

The company keeps gaining momentum thanks to the success of its AI-powered imaging software. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heartflow reports significant revenue growth as CCTA sees wider adoption

Share on Twitter Share on Facebook Share on Linkedin
The company keeps gaining momentum thanks to the success of its AI-powered imaging software. 
READ MORE >

Featured Articles

Compensation in cardiology now outpacing all other healthcare specialties

Physician compensation is rising faster in cardiology than any other specialty. Still, considering how demanding the job is, many cardiologists feel underpaid.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Compensation in cardiology now outpacing all other healthcare specialties

Share on Twitter Share on Facebook Share on Linkedin
Physician compensation is rising faster in cardiology than any other specialty. Still, considering how demanding the job is, many cardiologists feel underpaid.
READ MORE >

Cardiac amyloidosis in the spotlight at Heart Failure 2026

Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.

READ MORE >
Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA
Share on Twitter Share on Facebook Share on Linkedin

Cardiac amyloidosis in the spotlight at Heart Failure 2026

Share on Twitter Share on Facebook Share on Linkedin
Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA
Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.
READ MORE >

Blood pressure drug recalled after failed test

Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Blood pressure drug recalled after failed test

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.
READ MORE >

Cardiologists are first in world to use new leaflet-splitting technique during TAVR

Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists are first in world to use new leaflet-splitting technique during TAVR

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.
READ MORE >

In Case You Missed It

Multiple GLP-1 drugs linked to lower AFib risk

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment. 

READ MORE >
GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.
Share on Twitter Share on Facebook Share on Linkedin

Multiple GLP-1 drugs linked to lower AFib risk

Share on Twitter Share on Facebook Share on Linkedin
GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment. 
READ MORE >

‘Father of modern cardiology’ Eugene Braunwald dies at 96

Colleagues from all over the world have shared loving tributes to Braunwald. ESC President Thomas F. Lüscher, MD, called him "the pioneering cardiologist of his time."

READ MORE >
Eugene Braunwald, MD
Share on Twitter Share on Facebook Share on Linkedin

‘Father of modern cardiology’ Eugene Braunwald dies at 96

Share on Twitter Share on Facebook Share on Linkedin
Eugene Braunwald, MD
Colleagues from all over the world have shared loving tributes to Braunwald. ESC President Thomas F. Lüscher, MD, called him "the pioneering cardiologist of his time."
READ MORE >

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

READ MORE >
Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B
Share on Twitter Share on Facebook Share on Linkedin

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Share on Twitter Share on Facebook Share on Linkedin
Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
READ MORE >

In Other News

Beware of temptations to commit 1 (or more) of the 7 deadly sins common to healthcare AI

Researchers warn of potential perdition—so to speak—for doing algorithmic medicine wrong in any of these easily avoidable ways. 

READ MORE >
angel devil temptation
Share on Twitter Share on Facebook Share on Linkedin

Beware of temptations to commit 1 (or more) of the 7 deadly sins common to healthcare AI

Share on Twitter Share on Facebook Share on Linkedin
angel devil temptation
Researchers warn of potential perdition—so to speak—for doing algorithmic medicine wrong in any of these easily avoidable ways. 
READ MORE >

Hospital missed woodland debris that led to post-amputation death of teenager, lawsuit alleges

Good Samaritan Regional Medical Center is named in a court filing against a physician at the facility who allegedly failed to clean a wound, leaving 12 pieces of twigs, moss and pine needles inside. The alleged victim, an 18-year-old man, later died.

READ MORE >
Tree
Share on Twitter Share on Facebook Share on Linkedin

Hospital missed woodland debris that led to post-amputation death of teenager, lawsuit alleges

Share on Twitter Share on Facebook Share on Linkedin
Tree
Good Samaritan Regional Medical Center is named in a court filing against a physician at the facility who allegedly failed to clean a wound, leaving 12 pieces of twigs, moss and pine needles inside. The alleged victim, an 18-year-old man, later died.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup